Skyline Venture Partners Qualified Purchaser Fund IV L P's Net Worth
-$2.34 Million
Who is Skyline Venture Partners Qualified Purchaser Fund IV L P?
Skyline Venture Partners Qualified Purchaser Fund IV L P does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, Targanta Therapeutics Corp., CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, ARCA biopharma, Inc., and ACELRX PHARMACEUTICALS INC.
SEC CIK
Skyline Venture Partners Qualified Purchaser Fund IV L P's CIK is 0001324617
Past Insider Trading and Trends
2013 was Skyline Venture Partners Qualified Purchaser Fund IV L P's most active year for acquiring shares with 5 total transactions. Skyline Venture Partners Qualified Purchaser Fund IV L P's most active month to acquire stocks was the month of February. 2014 was Skyline Venture Partners Qualified Purchaser Fund IV L P's most active year for disposing of shares, totalling 8 transactions. Skyline Venture Partners Qualified Purchaser Fund IV L P's most active month to dispose stocks was the month of September. 2013 saw Skyline Venture Partners Qualified Purchaser Fund IV L P paying a total of $4,767,084.00 for 2,179,800 shares, this is the most they've acquired in one year. In 2014 Skyline Venture Partners Qualified Purchaser Fund IV L P cashed out on 17,451,623 shares for a total of $560,380.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.49% | -295.51K |
—
|
—
| 1.89M |
Mar 12
| |||
Form 4
| +21,071.05% | 2.18M |
$7.00 |
—
| 2.19M |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Targanta Therapeutics Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.22M |
—
|
—
|
0
|
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CONCERT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,634.46% | 1.18M |
$14.00 |
—
| 1.21M |
Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PROTEON THERAPEUTICS INC (TARA) Snapshot price: $1.9505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.43M |
$8.98 | -$560,380.00 | 1.43M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACELRX PHARMACEUTICALS INC (ACRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -31.16% | -1.30M |
—
|
—
| 2.87M |
Mar 7
| |||
Form 4
| +7.34% | 284.7K |
$3.40 | $967,973.20 | 4.16M |
May 29
| |||
Form 4
| +147.17% | 3.89M |
$5.00 | $6,179,715.00 | 6.53M |
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |